U.S. Acute Hospital Care Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Acute Hospital Care Market 

5.1. COVID-19 Landscape: U.S. Acute Hospital Care Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Acute Hospital Care Market, By Medical Condition

8.1. U.S. Acute Hospital Care Market, by Medical Condition, 2024-2033

8.1.1 Emergency Care

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Short-term Stabilizatio

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Trauma Care

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Acute Care Surgery

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. U.S. Acute Hospital Care Market, By Facility Type

9.1. U.S. Acute Hospital Care Market, by Facility Type, 2024-2033

9.1.1. General Acute Care Hospitals

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Psychiatric Hospitals

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Specialized Hospitals

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Rehabilitation Hospitals

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Long-term Acute Care (LTAC)

9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. U.S. Acute Hospital Care Market, By Service 

10.1. U.S. Acute Hospital Care Market, by Service, 2024-2033

10.1.1. Intensive Care Unit (ICU)

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Neonatal Intensive Care Unit (NICU)

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Coronary Care Unit (CCU)

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 11. U.S. Acute Hospital Care Market, Regional Estimates and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Forecast, by Medical Condition (2021-2033)

11.1.2. Market Revenue and Forecast, by Facility Type (2021-2033)

11.1.3. Market Revenue and Forecast, by Service (2021-2033)

Chapter 12. Company Profiles

12.1. TH Medical (Tenet Healthcare Corporation)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Universal Health Services Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Community Health Systems, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Ascension

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Lifepoint Health, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Ardent Health Services

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Emerus Hospital Partners, LLC

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Emerus Hospital Partners, LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. NYU Langone Hospitals

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. NewYork-Presbyterian Hospital

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms